Call toll-free 800.328.1267
Market Insights has covered the split between the new winners and losers in technology. Something similar seems to be underway in the health-care sector. Drug makers whose products offer the promise of growth have led. These includes biotechnology stocks, which keep...
No, it wasn't a nightmare. There was a lot of bad news on a lot of companies last week. At least five of the 30 members of the Dow Jones Industrial Average dropped amid some kind of bearish headline: Apple (AAPL): Wall Street analysts continued to hammer the...
A lot of catalysts are vying for attention after last week's sharp drop, but two earlier trends seem to remain intact. First, health-care stocks enjoyed surprising positive results last earnings season. That made the SPDR Health Care ETF (XLV) the best-performing...
News reports have seen it coming for months, but now it's official: Amazon.com (AMZN) is attacking drug distributors. AMZN announced the purchase of closely held PillPack. The smaller company caters to patients who routinely take large numbers of medicines, like for...
Buy at support, sell at resistance, but always back-test. That was the message from our pro trader this morning. Price Headly, founder of BigTrends.com, runs Donchian channels on his TradeStation platform to time entries and exits. Like many other power users, he's...